UB Paderborn / Katalog / Suche / in CDI

Population Pharmacokinetic Model of Amiodarone and N-Desethylamiodarone Focusing on Glucocorticoid and Inflammation

Biological and Pharmaceutical Bulletin, 2022/07/01, Vol.45(7), pp.948-954

2022

Volltextzugriff (PDF)

Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia

Journal of pharmaceutical sciences, 2021-05, Vol.110 (5), p.2295-2300

2021

Volltextzugriff (PDF)

Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients

British journal of clinical pharmacology, 2017-08, Vol.83 (8), p.1758-1772

2017

Volltextzugriff (PDF)

Pharmacodynamic Model-Based Safety Management of Eribulin-Induced Myelosuppression in Patients With Breast Cancer

Therapeutic drug monitoring, 2023-06, Vol.45 (3), p.318

2023

Volltextzugriff (PDF)

Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data

Cancer science, 2018-09, Vol.109 (9), p.2822-2829

2018

Volltextzugriff (PDF)

Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2018-04, Vol.24 (4), p.284-291

2018

Volltextzugriff (PDF)

An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1)

Drug metabolism and pharmacokinetics, 2018-08, Vol.33 (4), p.188-193

2018

Volltextzugriff (PDF)

Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance data

CPT: pharmacometrics and systems pharmacology, 2022-01, Vol.11 (1), p.44-54

2022

Volltextzugriff (PDF)

Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data

BMC pharmacology & toxicology, 2022-02, Vol.23 (1), p.14-14, Article 14

2022

Volltextzugriff (PDF)

Pharmacodynamic analysis of hypertension caused by lenvatinib using real‐world postmarketing surveillance data

CPT: pharmacometrics and systems pharmacology, 2021-03, Vol.10 (3), p.188-198

2021

Volltextzugriff (PDF)

Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem‐Cell Transplantation

Journal of clinical pharmacology, 2018-09, Vol.58 (9), p.1140-1149

2018

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function

Antibiotics (Basel), 2022-03, Vol.11 (4), p.456

2022

Volltextzugriff (PDF)

Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures

International journal of infectious diseases, 2017-04, Vol.57 (C), p.38-43

2017

Volltextzugriff (PDF)

Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers

European journal of clinical pharmacology, 2013-03, Vol.69 (3), p.489-497

2013

Volltextzugriff (PDF)

Population Pharmacokinetic Approach to the Use of Low Dose Cyclosporine in Patients with Connective Tissue Diseases

Biological and Pharmaceutical Bulletin, 2015/09/01, Vol.38(9), pp.1265-1271

2015

Volltextzugriff (PDF)

Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms

European journal of drug metabolism and pharmacokinetics, 2019-06, Vol.44 (3), p.329-338

2019

Volltextzugriff (PDF)

Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer

Cancer chemotherapy and pharmacology, 2020-10, Vol.86 (4), p.487-495

2020

Volltextzugriff (PDF)

Pharmacokinetic–pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2011-04, Vol.17 (2), p.224-230

2011

Volltextzugriff (PDF)

Intestinal obstruction and phenytoin intoxication

Pediatrics international, 2009-06, Vol.51 (3), p.431-432

2009

Volltextzugriff (PDF)

Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid

Journal of clinical pharmacology, 2021-05, Vol.61 (5), p.606-613

2021

Volltextzugriff (PDF)

Population Pharmacokinetics of Landiolol Hydrochloride in Healthy Subjects

DRUG METABOLISM AND PHARMACOKINETICS, 2008-01, Vol.23 (6), p.447-455

2008

Volltextzugriff (PDF)

Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2023-12, Vol.29 (12), p.1152-1159

2023

Volltextzugriff (PDF)

Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation: Characteristics of 5 representative reagents in Japan (CVI ARO 1)

Thrombosis research, 2017-02, Vol.150, p.73-75

2017

Volltextzugriff (PDF)

Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis

European journal of drug metabolism and pharmacokinetics, 2023-03, Vol.48 (2), p.201-211

2023

Volltextzugriff (PDF)

Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study

Investigational new drugs, 2023-02, Vol.41 (1), p.122-133

2023

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Population Pharmacokinetic Model of Amiodarone and N-Desethylamiodarone Focusing on Glucocorticoid and Inflammation

Classification Tree Analysis Based On Machine Learning for Predicting Linezolid-Induced Thrombocytopenia

Population pharmacokinetics and pharmacodynamics of linezolid‐induced thrombocytopenia in hospitalized patients

Pharmacodynamic Model-Based Safety Management of Eribulin-Induced Myelosuppression in Patients With Breast Cancer

Pharmacodynamic analysis of eribulin safety in breast cancer patients using real‐world postmarketing surveillance data

Population pharmacokinetics of teicoplanin in hospitalized elderly patients using cystatin C as an indicator of renal function

An analysis on distribution and inter-relationships of biomarkers under rivaroxaban in Japanese patients with non-valvular atrial fibrillation (CVI ARO 1)

Pharmacometric analysis of seasonal influenza epidemics and the effect of vaccination using sentinel surveillance data

Population pharmacokinetic analysis and dosage recommendations for digoxin in Japanese patients with atrial fibrillation and heart failure using real-world data

Pharmacodynamic analysis of hypertension caused by lenvatinib using real‐world postmarketing surveillance data

Population Pharmacokinetics of Vancomycin in Patients Undergoing Allogeneic Hematopoietic Stem‐Cell Transplantation

Pharmacokinetic/Pharmacodynamic Analysis and Dose Optimization of Cefmetazole and Flomoxef against Extended-Spectrum β-Lactamase-Producing Enterobacterales in Patients with Invasive Urinary Tract Infection Considering Renal Function

Evaluation of pharmacokinetics and the stability of daptomycin in serum at various temperatures

Population pharmacokinetics of phenytoin after intravenous administration of fosphenytoin sodium in pediatric patients, adult patients, and healthy volunteers

Population Pharmacokinetic Approach to the Use of Low Dose Cyclosporine in Patients with Connective Tissue Diseases

Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms

Pharmacokinetic and pharmacodynamic analysis of neutropenia following nab-paclitaxel administration in Japanese patients with metastatic solid cancer

Pharmacokinetic–pharmacodynamic study of itraconazole in patients with fungal infections in intensive care units

Intestinal obstruction and phenytoin intoxication

Prediction of Fracture Risk From Early‐Stage Bone Markers in Patients With Osteoporosis Treated With Once‐Yearly Administered Zoledronic Acid

Population Pharmacokinetics of Landiolol Hydrochloride in Healthy Subjects

Comparison of the predictive accuracy of the physiologically based pharmacokinetic (PBPK) model and population pharmacokinetic (PPK) model of vancomycin in Japanese patients with MRSA infection

Response of prothrombin time to rivaroxaban in Japanese patients with non-valvular atrial fibrillation: Characteristics of 5 representative reagents in Japan (CVI ARO 1)

Population Pharmacokinetic Model for Unbound Concentrations of Daptomycin in Patients with MRSA Including Patients Undergoing Hemodialysis

Population Pharmacokinetics, Pharmacogenomics, and Adverse Events of Osimertinib and its Two Active Metabolites, AZ5104 and AZ7550, in Japanese Patients with Advanced Non-small Cell Lung Cancer: a Prospective Observational Study

Suchergebnisse filtern